why choose us

First received: July 25, 2023

Clinical Trial: Study of 11C-HY-2-15

Study Status: Completed

Recruit Status: RECRUITING

Condition: Tauopathies

Study Type: INTERVENTIONAL


Official Title: Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Phase I Pilot Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15

Brief Summary: The current protocol is to determine the biodistribution, metabolism, excretion and brain uptake of 11C HY-2-15.The goal of this radiotracer is to quantify alpha-synuclein that is abnormally deposited in the brain of people with Multiple System Atrophy (MSA).The investigators will compare uptake in people with MSA with people with Parkinson disease (PD) and progressive supranuclear palsy (PSP) as well as healthy volunteers.This multicenter project funded by an NIH U19 grant, is centered at U Pennsylvania (Penn,…

Read more